We are live on
!
Find out more
TC
TradeLink Capital Portfolio holdings
AUM
$13.2M
1-Year Est. Return
33.27%
This Fund
S&P 500
This Quarter
Est. Return
+10.79%
1 Year Est. Return
+33.27%
3 Year Est. Return
+48.31%
5 Year Est. Return
+69.64%
10 Year Est. Return
+1,512.66%
AUM
$43.5M
AUM Growth
-$280M
(-87%)
Cap. Flow
-$286M
Cap. Flow
% of AUM
-657.55%
Top 10 Holdings %
Top 10 Hldgs %
18.59%
Holding
482
New
70
Increased
7
Reduced
147
Closed
258
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNH
CNH GLOBAL N.V. (NEW)
CNH
|
+$1.81M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$710K |
| 3 |
Delta Air Lines
DAL
|
+$587K |
| 4 |
Franco-Nevada
FNV
|
+$532K |
| 5 |
Walt Disney
DIS
|
+$526K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$86M |
| 2 |
Zoetis
ZTS
|
+$24.2M |
| 3 |
ExxonMobil
XOM
|
+$8.76M |
| 4 |
IBM
IBM
|
+$5.46M |
| 5 |
SDRL
Seadrill Limited Common Stock
SDRL
|
+$4.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.63% |
| 2 | Technology | 17.32% |
| 3 | Consumer Discretionary | 13.2% |
| 4 | Healthcare | 11.12% |
| 5 | Communication Services | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Gilead Sciences
GILD
$167B
| $57K | 0.13% |
+900
| New | +$53.8K |
|
177
Amgen
AMGN
$210B
| $56K | 0.13% |
500
-17,600
| -97% | -$1.91M |
|
178
Intel
INTC
$424B
| $55K | 0.13% |
2,400
-73,700
| -97% | -$1.7M |
|
|
SNI
179
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $55K | 0.13% |
700
-3,200
| -82% | -$236K |
|
180
Blackrock
BLK
$170B
| $54K | 0.12% |
+200
| New | +$54.3K |
|
|
GRMN
181
Garmin
GRMN
$57.9B
| $54K | 0.12% |
1,200
-1,300
| -52% | -$51.6K |
|
|
HES
182
DELISTED
Hess
HES
| $54K | 0.12% |
+700
| New | +$52.1K |
|
183
Morgan Stanley
MS
$325B
| $54K | 0.12% |
+2,000
| New | +$53.7K |
|
184
CME Group
CME
$95.3B
| $52K | 0.12% |
700
-6,000
| -90% | -$442K |
|
185
W.W. Grainger
GWW
$64.5B
| $52K | 0.12% |
200
-100
| -33% | -$26K |
|
186
Ecolab
ECL
$78.7B
| $49K | 0.11% |
+500
| New | +$46.5K |
|
187
Jefferies Financial Group
JEF
$12.7B
| $46K | 0.11% |
1,899
-2,234
| -54% | -$53.5K |
|
188
State Street
STT
$49B
| $46K | 0.11% |
+700
| New | +$47.9K |
|
|
CELG
189
DELISTED
Celgene Corp
CELG
| $46K | 0.11% |
+600
| New | +$42K |
|
|
BCR
190
DELISTED
CR Bard Inc.
BCR
| $46K | 0.11% |
400
-2,300
| -85% | -$264K |
|
191
Nabors Industries
NBR
$1.18B
| $45K | 0.1% |
+56
| New | +$44K |
|
192
Procter & Gamble
PG
$338B
| $45K | 0.1% |
+600
| New | +$47.7K |
|
193
Northern Trust
NTRS
$22B
| $44K | 0.1% |
800
-3,600
| -82% | -$207K |
|
|
COV
194
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $43K | 0.1% |
700
-5,730
| -89% | -$350K |
|
195
Colgate-Palmolive
CL
$74.2B
| $42K | 0.1% |
700
-15,200
| -96% | -$901K |
|
196
Verizon
VZ
$201B
| $42K | 0.1% |
+900
| New | +$43.9K |
|
197
CVS Health
CVS
$137B
| $40K | 0.09% |
700
-26,600
| -97% | -$1.59M |
|
198
DaVita
DVA
$15.5B
| $40K | 0.09% |
700
-3,700
| -84% | -$212K |
|
199
Marriott International
MAR
$100B
| $38K | 0.09% |
900
-2,600
| -74% | -$108K |
|
200
Starbucks
SBUX
$118B
| $38K | 0.09% |
1,000
-19,800
| -95% | -$712K |
|
Similar funds
PSFG
SCI
GBCP
IWM
DOFI
RC
M
AWGLSCP
TradeLink Capital's Q3 2013 Portfolio in Review
As of Q3 2013, TradeLink Capital held 482 positions worth $43.5M, down 87% from $324M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
TradeLink Capital withdrew a net $286M in Q3 2013, closing 258 positions and reducing 147 holdings. Its most notable exit was Zoetis, an estimated $24.2M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 6.7% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TradeLink Capital opened a new position in CNH GLOBAL N.V. (NEW) worth $1.96M.
- TradeLink Capital's largest Q3 2013 buy was CNH GLOBAL N.V. (NEW): 39,185 shares worth $1.96M.
- TradeLink Capital added most to Delta Air Lines in Q3 2013, an estimated $587K increase.
- TradeLink Capital's biggest Q3 2013 reduction was Pfizer, cutting an estimated $86M.
- TradeLink Capital fully exited Zoetis in Q3 2013, selling an estimated $24.2M.
- TradeLink Capital's ten largest holdings make up 19% of its $43.5M portfolio in Q3 2013.
- TradeLink Capital opened 70 new positions and closed 258 in Q3 2013.
- TradeLink Capital's portfolio value fell 87% quarter-over-quarter to $43.5M.
Based on TradeLink Capital's 13F filing for Q3 2013, filed 12 Nov 2013.